Advancing Knowledge. Enhancing Care.
Advancing Knowledge. Enhancing Care.

Psoriasis News

the latest news from ipc, industry and others

IPC General

Displaying 1 to 10 of 128 Posts . Displaying 10 of Posts . Page of 13 . Go To Page: . Per Page: . . . View All Sort By: .

INSIDE LOOK campaign raises awareness about plaque psoriasis

Amgen and Otezla® (apremilast) have partnered with Allan Avendaño, makeup artist to Hollywood A-listers, for the INSIDE LOOK campaign to share his journey living with plaque psoriasis and the difficulties of being in his demanding role and dealing with a chronic skin condition.

Read More

Dermavant submits New Drug Application to FDA for tapinarof cream for the treatment plaque psoriasis

Dermavant Sciences announced on June 3, 2021 that it has submitted a New Drug Application to the U.S. Food and Drug Administration for tapinarof for the treatment of mild, moderate and severe plaque psoriasis in adult patients.

Read More

IPC International Fellow wins first prize for 2021 RADLA Poster Presentation

2019 IPC Fellow Romina Contreras was recognized at the 2021 Virtual RADLA Congress, winning first prize for her poster presentation.

Read More

New data from the PsoProtect Registry

Update on the PsoProtect Registry. PsoProtect is a global registry for clinicians to report outcomes of COVID-19 in individuals with psoriasis. Data set currently includes 1,118 cases.

Read More

Serie de Videos Sobre la Reclasificación de la Gravedad de la Psoriasis del IPC

Conozca cómo se mide actualmente la gravedad de la psoriasis y por qué es necesario un cambio, cómo el IPC organizó el proceso Delphi que se utilizó para redefinir la clasificación de la gravedad, las implicaciones y los efectos que tiene el resultado en los proveedores de tratamiento de la psoriasis y los pacientes con psoriasis y, en última instancia, cómo los pacientes se beneficiarán de esto. esfuerzo.

Read More

Expert Opinion: Psoriasis comprehensive review

The review is up-to-date and discusses the current knowledge and challenges in managing psoriasis during the SARS-CoV-2 pandemic and nicely points out future directions of psoriasis research by highlighting unresolved questions, new developments, and unmet medical needs.

Read More

Commentary: Sex differences in immune responses that underlie COVID-19 disease outcomes

Because of the growing body of evidence indicating sex differences in the clinical outcomes of coronavirus disease 2019 (COVID-19) infection, the IMPACT Research Team from Yale University investigated sex differences in viral loads, SARS-CoV-2-specific antibody titers, plasma cytokines, as well as blood cell phenotyping in COVID-19 patients.

Read More

Video Series on IPC’s Psoriasis Severity Reclassification

Learn how psoriasis severity is currently measured and why a change is necessary, how IPC organized the Delphi process that was used to redefine severity classification, implications and effects the output has on psoriasis treatment providers and psoriasis patients, and ultimately how patients will benefit from this endeavor.

Read More

Janssen Phase-3 TREMFYA® Clinical Trial

Janssen Pharmaceutical Companies of Johnson & Johnson published the long-term data of the third phase of the DISCOVER-2a study.

Read More

Sun Pharma Phase-3 ILUMYA® Clinical Trial

Sun Pharmaceutical Industries Inc. announces results from their five-year Phase-3 efficacy and safety clinical trial for ILUMYA®(tildrakizumab-asmn) based on a pooled analysis of the ReSURFACE 1 and ReSURFACE 2 extension.

Read More

Stay informed

Join the email list to receive the latest information on psoriasis meetings, manuscripts and research.
SUBSCRIBE

now available

COVID-19 Psoriasis Resource Center

Information from around the world on psoriasis and coronavirus to assist dermatologists and the patients they serve

explore now

 

We use cookies on this site to enhance your online experience. By continuing to use this site, you agree to accept cookies.
OK